XBIO financials
Xenetic Biosciences (XBIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- XBIO revenue was $2.98M in fiscal 2025, net income -$2.68M.
XBIO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $2.98M | – | -$2.83M | -$2.68M | -1.58 |
| 2024 | $2.50M | – | -$4.20M | -$3.96M | -2.57 |
| 2023 | $2.54M | – | -$4.52M | -$4.13M | -2.71 |
| 2022 | $1.71M | – | -$6.72M | -$6.55M | -4.61 |
| 2021 | $1.16M | – | -$5.75M | -$5.65M | -5.50 |
| 2020 | $436.94K | – | -$13.94M | -$10.89M | -17.00 |